Bavarian Nordic receives Swiss order for 100,000 monkeypox doses
The Danish drugmaker does not think the order will impact its financial guidance for 2022.
by marketwire, translated by daniel pedersen
Bavarian Nordic has entered a supply agreement with Switzerland regarding the company’s vaccine against monkeypox and smallpox, a press release announces.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
